Seth A Darst Selected Research

Communicable Diseases (Infectious Diseases)

12/2020

The antibiotic sorangicin A inhibits promoter DNA unwinding in a Mycobacterium tuberculosis rifampicin-resistant RNA polymerase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seth A Darst Research Topics

Disease

7	Tuberculosis (Tuberculoses) 12/2020 - 02/2005
4	Infections 01/2020 - 01/2011
2	Cystic Fibrosis (Mucoviscidosis) 11/2023 - 01/2020
2	COVID-19 01/2023 - 12/2021
1	Communicable Diseases (Infectious Diseases) 12/2020
1	Superinfection 01/2017
1	Starvation 10/2012

Drug/Important Bio-Agent (IBA)

5	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2020 - 10/2012
3	Rifampin (Rifampicin)FDA LinkGeneric 12/2020 - 02/2005
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 10/2012
1	Peptides (Polypeptides)IBA 11/2023
1	VaccinesIBA 01/2023
1	Complement System Proteins (Complement)IBA 12/2021
1	Synthetic DrugsIBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2018
1	RifamycinsIBA 10/2018
1	Bacterial RNAIBA 10/2018
1	HoloenzymesIBA 01/2018
1	FidaxomicinIBA 01/2018
1	16S Ribosomal RNAIBA 01/2017
1	NucleotidesIBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Rifabutin (Ansamycin)FDA Link 02/2005

Therapy/Procedure

1	Therapeutics 12/2021